Feasibility and safety of intranasally administered mesenchymal stromal cells after perinatal arterial ischaemic stroke in the Netherlands (PASSIoN): a first-in-human, open-label intervention study
Lisanne M. Baak, Nienke Wagenaar, Niek E. van der Aa, Floris Groenendaal, Jeroen Dudink, Maria Luisa Tataranno, Ubah Mahamuud, Cornelia H. Verhage, Rian M. J. C. Eijsermans, Liesbeth S. Smit, Reint K. Jellema, Timo R. de Haan, Hendrik J. ter Horst, Willem P. de Boode, Sylke J. Steggerda, Henk‐Jan Prins, Colin de Haar, Linda S. de Vries, Frank van Bel, Cobi J. Heijnen, Cora H. Nijboer, Manon J.N.L. Benders
Topics & Concepts
Mesenchymal stem cellMedicineNasal administrationIntervention (counseling)Stroke (engine)PassionStromal cellIschaemic strokeInternal medicinePathologyIschemiaImmunologyPsychologyPsychiatryEngineeringPsychotherapistMechanical engineeringMesenchymal stem cell researchNeonatal and fetal brain pathologyMoyamoya disease diagnosis and treatment